Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INCB086550 in Advanced Solid Tumors
NCT04629339Phase 2Terminated
- Sponsor
- Incyte
- Start
- Sep 2021
- Primary completion
- Mar 2024
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of incb086550 in non-small cell lung cancer (NSCLC), urothelial carcinoma (UC), renal cell carcinoma (RCC), hepatocellular carcinoma (HCC), melanoma, sponsored by Incyte. Started Sep 2021; status: terminated.
02
Drugs
incb086550
03
Conditions
non-small cell lung cancer (NSCLC)urothelial carcinoma (UC)renal cell carcinoma (RCC)hepatocellular carcinoma (HCC)melanoma
Beyond the preview
Go deeper on NCT04629339.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04629339.